Cancer
MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma.
Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, Xiao L, Liu X, Wang R, Li X, Wu M, Li G.
Mol Cancer. 2011 Sep 30;10:124.
MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes.
Faragó N, Fehér LZ, Kitajka K, Das UN, Puskás LG.
Lipids Health Dis. 2011 Sep 30;10:173.
Autoregulatory suppression of c-Myc by miR-185-3p.
Liao JM, Lu H.
J Biol Chem. 2011 Sep 30;286(39):33901-9.
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions.
Grignol V, Fairchild ET, Zimmerer JM, Lesinski GB, Walker MJ, Magro CM, Kacher JE, Karpa VI, Clark J, Nuovo G, Lehman A, Volinia S,
Agnese DM, Croce CM, Carson WE 3rd.
Br J Cancer. 2011 Sep 27;105(7):1023-9.
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155.
Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L; Kathleen Cuningham Foundation Consortium for Research into Familial
Breast Cancer (kConFab), Haines DC, Basik M, Mai P, Poggi E, Isaacs C, Looi LM, Mun KS, Greene MH, Byers SW, Teo SH, Deng CX,
Sharan SK.
Nat Med. 2011 Sep 25;17(10):1275-82.
MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.
Rota R, Ciarapica R, Giordano A, Miele L, Locatelli F.
Mol Cancer. 2011 Sep 24;10:120.
Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and
senescence in primary cells.
Tzatsos A, Paskaleva P, Lymperi S, Contino G, Stoykova S, Chen Z, Wong KK, Bardeesy N.
J Biol Chem. 2011 Sep 23;286(38):33061-9.
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells.
Yang M, Chen J, Su F, Yu B, Su F, Lin L, Liu Y, Huang JD, Song E.
Mol Cancer. 2011 Sep 22;10:117.
Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells.
Hao M, Zhang L, An G, Sui W, Yu Z, Zou D, Xu Y, Chang H, Qiu L.
J Hematol Oncol. 2011 Sep 22;4:37.
Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer.
Reimer D, Hubalek M, Kiefel H, Riedle S, Skvortsov S, Erdel M, Hofstetter G, Concin N, Fiegl H, Müller-Holzner E, Marth C, Altevogt P,
Zeimet AG.
Oncogene. 2011 Sep 22;30(38):4038-49.
MicroRNAs as a potential prognostic factor in gastric cancer.
Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N,
Chajut A, Niv Y, Kushnir M.
World J Gastroenterol. 2011 Sep 21;17(35):3976-85.
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma.
Jin L, Hu WL, Jiang CC, Wang JX, Han CC, Chu P, Zhang LJ, Thorne RF, Wilmott J, Scolyer RA, Hersey P, Zhang XD, Wu M.
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15840-5.
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1
dependent mechanism.
Sureban SM, May R, Mondalek FG, Qu D, Ponnurangam S, Pantazis P, Anant S, Ramanujam RP, Houchen CW.
J Nanobiotechnology. 2011 Sep 19;9:40.
MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme.
Li WB, Ma MW, Dong LJ, Wang F, Chen LX, Li XR.
Cancer Biol Ther. 2011 Sep 15;12(6):477-83.
Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system.
Kossenkov AV, Vachani A, Chang C, Nichols C, Billouin S, Horng W, Rom WN, Albelda SM, Showe MK, Showe LC.
Clin Cancer Res. 2011 Sep 15;17(18):5867-77.
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia.
Visone R, Veronese A, Rassenti LZ, Balatti V, Pearl DK, Acunzo M, Volinia S, Taccioli C, Kipps TJ, Croce CM.
Blood. 2011 Sep 15;118(11):3072-9.
MicroRNA regulation of cancer stem cells.
Liu C, Tang DG.
Cancer Res. 2011 Sep 15;71(18):5950-4.
WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis
cascade.
Sossey-Alaoui K, Downs-Kelly E, Das M, Izem L, Tubbs R, Plow EF.
Int J Cancer. 2011 Sep 15;129(6):1331-43.
Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.
Wang X, Meyers C, Guo M, Zheng ZM.
Int J Cancer. 2011 Sep 15;129(6):1362-72.
Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the
thyroid gland?
Lassalle S, Hofman V, Ilie M, Bonnetaud C, Puisségur MP, Brest P, Loubatier C, Guevara N, Bordone O, Cardinaud B, Lebrigand K, Rios
G, Santini J, Franc B, Mari B, Al Ghuzlan A, Vielh P, Barbry P, Hofman P.
Endocr Relat Cancer. 2011 Sep 13;18(5):579-94.
microRNA-101 is a potent inhibitor of autophagy.
Frankel LB, Wen J, Lees M, Høyer-Hansen M, Farkas T, Krogh A, Jäättelä M, Lund AH.
EMBO J. 2011 Sep 13;30(22):4628-41.
The role of miR-506 in transformed 16HBE cells induced by anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide.
Zhao Y, Liu H, Li Y, Wu J, Greenlee AR, Yang C, Jiang Y.
Toxicol Lett. 2011 Sep 10;205(3):320-6.
Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Yan W, Zhang W, Sun L, Liu Y, You G, Wang Y, Kang C, You Y, Jiang T.
Brain Res. 2011 Sep 9;1411:108-15.
Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen.
Wang Q, Li DC, Li ZF, Liu CX, Xiao YM, Zhang B, Li XD, Zhao J, Chen LP, Xing XM, Tang SF, Lin YC, Lai YD, Yang P, Zeng JL, Xiao Q,
Zeng XW, Lin ZN, Zhuang ZX, Zhuang SM, Chen W.
Oncogene. 2011 Sep 8;30(36):3875-86.
The social aspects of EMT-MET plasticity.
Thompson EW, Haviv I.
Nat Med. 2011 Sep 7;17(9):1048-9.
Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation.
Pospisil V, Vargova K, Kokavec J, Rybarova J, Savvulidi F, Jonasova A, Necas E, Zavadil J, Laslo P, Stopka T.
EMBO J. 2011 Sep 6;30(21):4450-64.
Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma.
Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Fujimura L, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Katayama A,
Harabuchi Y, Okamoto Y, Seki N.
Br J Cancer. 2011 Sep 6;105(6):833-41.
Nanopore-based detection of circulating microRNAs in lung cancer patients.
Wang Y, Zheng D, Tan Q, Wang MX, Gu LQ.
Nat Nanotechnol. 2011 Sep 4;6(10):668-74.
DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor
survival.
Luk JM, Burchard J, Zhang C, Liu AM, Wong KF, Shek FH, Lee NP, Fan ST, Poon RT, Ivanovska I, Philippar U, Cleary MA, Buser CA,
Shaw PM, Lee CN, Tenen DG, Dai H, Mao M.
J Biol Chem. 2011 Sep 2;286(35):30706-13.
Multi-input RNAi-based logic circuit for identification of specific cancer cells.
Xie Z, Wroblewska L, Prochazka L, Weiss R, Benenson Y.
Science. 2011 Sep 2;333(6047):1307-11.
MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma.
Preis M, Gardner TB, Gordon SR, Pipas JM, Mackenzie TA, Klein EE, Longnecker DS, Gutmann EJ, Sempere LF, Korc M.
Clin Cancer Res. 2011 Sep 1;17(17):5812-21.
miR-22 promotes HBV-related hepatocellular carcinoma development in males.
Jiang R, Deng L, Zhao L, Li X, Zhang F, Xia Y, Gao Y, Wang X, Sun B.
Clin Cancer Res. 2011 Sep 1;17(17):5593-603.
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.
Friboulet L, Barrios-Gonzales D, Commo F, Olaussen KA, Vagner S, Adam J, Goubar A, Dorvault N, Lazar V, Job B, Besse B, Validire P,
Girard P, Lacroix L, Hasmats J, Dufour F, André F, Soria JC.
Clin Cancer Res. 2011 Sep 1;17(17):5562-72.
microRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma?
Setoyama T, Zhang X, Natsugoe S, Calin GA.
Clin Cancer Res. 2011 Sep 1;17(17):5527-9.
miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, Li X, Ma J, Li G.
J Cell Sci. 2011 Sep 1;124(Pt 17):2997-3005.
Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia.
Zhang H, Luo XQ, Feng DD, Zhang XJ, Wu J, Zheng YS, Chen X, Xu L, Chen YQ.
Mol Cancer. 2011 Sep 1;10:108.
miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans.
Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC, Lin MT, Chu CY, Hua KT, Chen CN, Kuo TC, Chang KJ, Hsiao M, Chang YW,
Chen JS, Yang PC, Kuo ML.
J Clin Invest. 2011 Sep 1;121(9):3442-55.
Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.
Ugras S, Brill E, Jacobsen A, Hafner M, Socci ND, Decarolis PL, Khanin R, O'Connor R, Mihailovic A, Taylor BS, Sheridan R, Gimble JM,
Viale A, Crago A, Antonescu CR, Sander C, Tuschl T, Singer S.
Cancer Res. 2011 Sep 1;71(17):5659-69.
Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
Suzuki H, Takatsuka S, Akashi H, Yamamoto E, Nojima M, Maruyama R, Kai M, Yamano HO, Sasaki Y, Tokino T, Shinomura Y, Imai K,
Toyota M.
Cancer Res. 2011 Sep 1;71(17):5646-58.
microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression
profiling in breast cancer.
Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J.
Cancer Res. 2011 Sep 1;71(17):5635-45.
The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J.
Cancer Res. 2011 Sep 1;71(17):5765-78.
mir-11 limits the proapoptotic function of its host gene, dE2f1.
Truscott M, Islam AB, López-Bigas N, Frolov MV.
Genes Dev. 2011 Sep 1;25(17):1820-34.
Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.
Wu Y, Liu S, Xin H, Jiang J, Younglai E, Sun S, Wang H.
Cancer. 2011 Sep 1;117(17):3989-98.
MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW, Bosserhoff AK.
Int J Cancer. 2011 Sep 1;129(5):1064-74.
Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell.
Zhou J, Wang W.
J Surg Oncol. 2011 Sep 1;104(3):278-83.
miRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen
tissue.
Leite KR, Canavez JM, Reis ST, Tomiyama AH, Piantino CB, Sañudo A, Camara-Lopes LH, Srougi M.
Urol Oncol. 2011 Sep-Oct;29(5):533-7.
Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early
sign of invasion and hormone-refractory cancer?
Man YG, Fu SW, Liu AJ, Stojadinovic A, Izadjoo MJ, Chen L, Gardner WA.
Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):235-44.
Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition
in hepatocellular carcinoma.
He Y, Cui Y, Wang W, Gu J, Guo S, Ma K, Luo X.
Neoplasia. 2011 Sep;13(9):841-53.
Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining
treatment response in patients with metastatic prostate cancer.
Gonzales JC, Fink LM, Goodman OB Jr, Symanowski JT, Vogelzang NJ, Ward DC.
Clin Genitourin Cancer. 2011 Sep;9(1):39-45.
MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells.
Jiang L, Huang Q, Chang J, Wang E, Qiu X.
Exp Lung Res. 2011 Sep;37(7):387-98.
Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
Wang Q, Zhong M, Liu W, Li J, Huang J, Zheng L.
Exp Lung Res. 2011 Sep;37(7):427-34.
miR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathway.
Zhang S, Zhang C, Li Y, Wang P, Yue Z, Xie S.
Biomed Pharmacother. 2011 Sep;65(6):436-42.
Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b.
Ma YL, Zhang P, Wang F, Moyer MP, Yang JJ, Liu ZH, Peng JY, Chen HQ, Zhou YK, Liu WJ, Qin HL.
J Cell Mol Med. 2011 Sep;15(9):1941-54.
MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.
Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y, Wang X, Zhao Q, Ding J, Wu K, Fan D.
J Cell Mol Med. 2011 Sep;15(9):1887-95.
Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal
squamous cell carcinoma.
Akagi I, Miyashita M, Ishibashi O, Mishima T, Kikuchi K, Makino H, Nomura T, Hagiwara N, Uchida E, Takizawa T.
Dis Esophagus. 2011 Sep;24(7):523-30.
Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells.
Sakurai E, Maesawa C, Shibazaki M, Yasuhira S, Oikawa H, Sato M, Tsunoda K, Ishikawa Y, Watanabe A, Takahashi K, Akasaka T,
Masuda T.
Int J Oncol. 2011 Sep;39(3):665-72.
Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in
lung cancer cells.
Rai K, Takigawa N, Ito S, Kashihara H, Ichihara E, Yasuda T, Shimizu K, Tanimoto M, Kiura K.
Mol Cancer Ther. 2011 Sep;10(9):1720-7.
MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways.
Lim WK, Micklem G.
Mol Biosyst. 2011 Sep;7(9):2571-6.
MicroRNA and hepatocellular carcinoma: biology and prognostic significance.
Milazzo M, Fornari F, Gramantieri L.
Minerva Gastroenterol Dietol. 2011 Sep;57(3):257-71.
Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells.
Bae S, Lee EM, Cha HJ, Kim K, Yoon Y, Lee H, Kim J, Kim YJ, Lee HG, Jeung HK, Min YH, An S.
Mol Cells. 2011 Sep;32(3):243-9.
miRNAs in lung cancer: large roles for small players.
Cherni I, Weiss GJ.
Future Oncol. 2011 Sep;7(9):1045-55.
Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs.
Le MT, Shyh-Chang N, Khaw SL, Chin L, Teh C, Tay J, O'Day E, Korzh V, Yang H, Lal A, Lieberman J, Lodish HF, Lim B.
PLoS Genet. 2011 Sep;7(9):e1002242.
miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition.
Zhang Z, Liu S, Shi R, Zhao G.
Cancer Genet. 2011 Sep;204(9):486-91.
Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression.
Hao M, Zhang L, An G, Meng H, Han Y, Xie Z, Xu Y, Li C, Yu Z, Chang H, Qiu L.
Leuk Lymphoma. 2011 Sep;52(9):1787-94.
C-T variant in a miRNA target site of BCL2 is associated with increased risk of human papilloma virus related cervical cancer--an in silico
approach.
Reshmi G, Surya R, Jissa VT, Babu PS, Preethi NR, Santhi WS, Jayaprakash PG, Pillai MR.
Genomics. 2011 Sep;98(3):189-93.
The micros in harmony: microRNA and microenvironment.
Balakrishnan K, Gandhi V.
Leuk Lymphoma. 2011 Sep;52(9):1626-9.
miRNA response to DNA damage.
Wan G, Mathur R, Hu X, Zhang X, Lu X.
Trends Biochem Sci. 2011 Sep;36(9):478-84.
Identification of direct targets for the miR-17-92 cluster by proteomic analysis.
Kanzaki H, Ito S, Hanafusa H, Jitsumori Y, Tamaru S, Shimizu K, Ouchida M.
Proteomics. 2011 Sep;11(17):3531-9.
miR-101 DNA copy loss is a prominent subtype specific event in lung cancer.
Thu KL, Chari R, Lockwood WW, Lam S, Lam WL.
J Thorac Oncol. 2011 Sep;6(9):1594-8.
Microarray analysis of microRNA expression in skin of Xpc⁺/⁻ mice and wild-type mice.
Zhou B, Wu H, Li W, Liu W, Luo D.
Ir J Med Sci. 2011 Sep;180(3):721-6.
[Screening and identification of potential miRNA involved in ovarian cancer invasion and metastasis].
Liang SH, Li J, Al-beit M, Zhang J, Ma D, Lu X.
Zhonghua Zhong Liu Za Zhi. 2010 Sep;32(9):650-4.
Comprehensive patterns in microRNA regulation of transcription factors during tumor metastasis.
Reshmi G, Sona C, Pillai MR.
J Cell Biochem. 2011 Sep;112(9):2210-7.
Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells.
Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH.
J Cell Biochem. 2011 Sep;112(9):2296-306.
Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells.
Pan L, Gong Z, Zhong Z, Dong Z, Liu Q, Le Y, Guo J.
Mol Cell Biochem. 2011 Sep;355(1-2):257-63.
Finding cancer-associated miRNAs: methods and tools.
Oulas A, Karathanasis N, Louloupi A, Poirazi P.
Mol Biotechnol. 2011 Sep;49(1):97-107.
Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.
Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY, Lu WG, Xie X.
Eur J Cancer. 2011 Sep;47(14):2166-74.
MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha.
Leone V, D'Angelo D, Rubio I, de Freitas PM, Federico A, Colamaio M, Pallante P, Medeiros-Neto G, Fusco A.
J Clin Endocrinol Metab. 2011 Sep;96(9):E1388-98.
Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia.
Schotte D, Moqadam FA, Lange-Turenhout EA, Chen C, van Ijcken WF, Pieters R, den Boer ML.
Leukemia. 2011 Sep;25(9):1389-99.
TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21.
Liu C, Gao F, Li B, Mitchel RE, Liu X, Lin J, Zhao L, Cai J.
Leukemia. 2011 Sep;25(9):1516-9.
MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia.
Gao XN, Lin J, Gao L, Li YH, Wang LL, Yu L.
Leuk Res. 2011 Sep;35(9):1226-32.
microRNA-182 inhibits the proliferation and invasion of human lung adenocarcinoma cells through its effect on human cortical actin-
associated protein.
Zhang L, Liu T, Huang Y, Liu J.
Int J Mol Med. 2011 Sep;28(3):381-8.
Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers.
Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L.
Int J Mol Med. 2011 Sep;28(3):327-36.
Down-regulation of spinophilin in lung tumours contributes to tumourigenesis.
Molina-Pinelo S, Ferrer I, Blanco-Aparicio C, Peregrino S, Pastor MD, Alvarez-Vega J, Suarez R, Verge M, Marin JJ, Hernandez-Losa J,
Ramon y Cajal S, Paz-Ares L, Carnero A.
J Pathol. 2011 Sep;225(1):73-82.
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.
Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafà R, Magri E, Lunardi M, Munerato G, Querzoli G, Maestri I, Ulazzi L, Nenci I, Croce CM,
Lanza G, Querzoli P, Negrini M.
J Pathol. 2011 Sep;225(1):43-53.
Downregulation of Cockayne syndrome B protein reduces human 8-oxoguanine DNA glycosylase-1 expression and repair of UV radiation-
induced 8-oxo-7,8-dihydro-2'-deoxyguanine.
Javeri A, Guy Lyons J, Huang XX, Halliday GM.
Cancer Sci. 2011 Sep;102(9):1651-8.
Systematic exploration of cancer-associated microRNA through functional screening assays.
Izumiya M, Tsuchiya N, Okamoto K, Nakagama H.
Cancer Sci. 2011 Sep;102(9):1615-21.
Epigenetic silencing of MIR203 in multiple myeloma.
Wong KY, Liang R, So CC, Jin DY, Costello JF, Chim CS.
Br J Haematol. 2011 Sep;154(5):569-78.
Translational control of TOP2A influences doxorubicin efficacy.
Srikantan S, Abdelmohsen K, Lee EK, Tominaga K, Subaran SS, Kuwano Y, Kulshrestha R, Panchakshari R, Kim HH, Yang X, Martindale
JL, Marasa BS, Kim MM, Wersto RP, Indig FE, Chowdhury D, Gorospe M.
Mol Cell Biol. 2011 Sep;31(18):3790-801.
miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of
miRNA dysregulation.
White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, Pace KT, Bjarnason GA,
Yousef GM.
J Urol. 2011 Sep;186(3):1077-83.
[Current status and development of miRNA and siRNA research on gastric cancer].
He M, Wang ZW.
Yi Chuan. 2011 Sep;33(9):925-30.
MicroRNA-146a inhibits glioma development by targeting Notch1.
Mei J, Bachoo R, Zhang CL.
Mol Cell Biol. 2011 Sep;31(17):3584-92.
Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells.
Rajabi H, Joshi MD, Jin C, Ahmad R, Kufe D.
Prostate. 2011 Sep;71(12):1299-308.
TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug.
Slabáková E, Pernicová Z, Slavíčková E, Staršíchová A, Kozubík A, Souček K.
Prostate. 2011 Sep;71(12):1332-43.
Reducing the risk of overdiagnosis in lung cancer: a support from molecular biology.
Barba M, Felsani A, Rinaldi M, Giunta S, Malorni W, Paggi MG.
J Cell Physiol. 2011 Sep;226(9):2213-4.
Expression of members of the miRNA17-92 cluster during development and in carcinogenesis.
Jevnaker AM, Khuu C, Kjøle E, Bryne M, Osmundsen H.
J Cell Physiol. 2011 Sep;226(9):2257-66.
MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703.
Hou YY, Cao WW, Li L, Li SP, Liu T, Wan HY, Liu M, Li X, Tang H.
Cancer Lett. 2011 Aug 28;307(2):182-90.
MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
Noguchi S, Mori T, Hoshino Y, Maruo K, Yamada N, Kitade Y, Naoe T, Akao Y.
Cancer Lett. 2011 Aug 28;307(2):211-20.
Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer.
Yun J, Frankenberger CA, Kuo WL, Boelens MC, Eves EM, Cheng N, Liang H, Li WH, Ishwaran H, Minn AJ, Rosner MR.
EMBO J. 2011 Aug 26;30(21):4500-14.
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression.
Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Körner S, Wang W, Boccaccio C, Thorgeirsson SS, Comoglio PM, Hermeking H,
Nikitin AY.
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14240-5.
Potentially predictive microRNAs of gastric cancer with metastasis to lymph node.
Wu WY, Xue XY, Chen ZJ, Han SL, Huang YP, Zhang LF, Zhu GB, Shen X.
World J Gastroenterol. 2011 Aug 21;17(31):3645-51.
CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells.
Schraivogel D, Weinmann L, Beier D, Tabatabai G, Eichner A, Zhu JY, Anton M, Sixt M, Weller M, Beier CP, Meister G.
EMBO J. 2011 Aug 19;30(20):4309-22.
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N.
Mol Cancer. 2011 Aug 18;10:99.
MicroRNA29a regulates the expression of the nuclear oncogene Ski.
Teichler S, Illmer T, Roemhild J, Ovcharenko D, Stiewe T, Neubauer A.
Blood. 2011 Aug 18;118(7):1899-902.
miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon
R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D.
Sci Signal. 2011 Aug 16;4(186):pt5.
Coordinated regulation of polycomb group complexes through microRNAs in cancer.
Cao Q, Mani RS, Ateeq B, Dhanasekaran SM, Asangani IA, Prensner JR, Kim JH, Brenner JC, Jing X, Cao X, Wang R, Li Y, Dahiya A,
Wang L, Pandhi M, Lonigro RJ, Wu YM, Tomlins SA, Palanisamy N, Qin Z, Yu J, Maher CA, Varambally S, Chinnaiyan AM.
Cancer Cell. 2011 Aug 16;20(2):187-99.
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R.
Clin Cancer Res. 2011 Aug 15;17(16):5287-98.
Plasma microRNAs as novel biomarkers for early detection of lung cancer.
Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, Freter CE, Wang MX.
Int J Clin Exp Pathol. 2011 Aug 15;4(6):575-86.
Immunophenotype-related microRNA expression in canine chronic lymphocytic leukemia.
Gioia G, Mortarino M, Gelain ME, Albonico F, Ciusani E, Forno I, Marconato L, Martini V, Comazzi S.
Vet Immunol Immunopathol. 2011 Aug 15;142(3-4):228-35.
MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2.
Shatseva T, Lee DY, Deng Z, Yang BB.
J Cell Sci. 2011 Aug 15;124(Pt 16):2826-36.
miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.
Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM, MacPherson D.
Genes Dev. 2011 Aug 15;25(16):1734-45.
miR than meets the eye.
Sage J, Ventura A.
Genes Dev. 2011 Aug 15;25(16):1663-7.
B-Myb, cancer, senescence, and microRNAs.
Martinez I, Dimaio D.
Cancer Res. 2011 Aug 15;71(16):5370-3.
miR 488* inhibits androgen receptor expression in prostate carcinoma cells.
Sikand K, Slaibi JE, Singh R, Slane SD, Shukla GC.
Int J Cancer. 2011 Aug 15;129(4):810-9.
ErbB2 down-regulates microRNA-205 in breast cancer.
Adachi R, Horiuchi S, Sakurazawa Y, Hasegawa T, Sato K, Sakamaki T.
Biochem Biophys Res Commun. 2011 Aug 12;411(4):804-8.
MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators.
Takata A, Otsuka M, Kojima K, Yoshikawa T, Kishikawa T, Yoshida H, Koike K.
Biochem Biophys Res Commun. 2011 Aug 12;411(4):826-31.
MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.
Oneyama C, Ikeda J, Okuzaki D, Suzuki K, Kanou T, Shintani Y, Morii E, Okumura M, Aozasa K, Okada M.
Oncogene. 2011 Aug 11;30(32):3489-501.
Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in
vivo.
Mullany LK, Fan HY, Liu Z, White LD, Marshall A, Gunaratne P, Anderson ML, Creighton CJ, Xin L, Deavers M, Wong KK, Richards JS.
Oncogene. 2011 Aug 11;30(32):3522-36.
Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients.
Stratmann J, Wang CJ, Gnosa S, Wallin A, Hinselwood D, Sun XF, Zhang H.
BMC Cancer. 2011 Aug 10;11:345.
Repression of human activation induced cytidine deaminase by miR-93 and miR-155.
Borchert GM, Holton NW, Larson ED.
BMC Cancer. 2011 Aug 10;11:347.
MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
Cai K, Wang Y, Bao X.
J Exp Clin Cancer Res. 2011 Aug 8;30:73.
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia BA,
Ragoussis J, Amadori D, Harris AL, Kang Y.
Nat Med. 2011 Aug 7;17(9):1101-8.
MicroRNA regulation by RNA-binding proteins and its implications for cancer.
van Kouwenhove M, Kedde M, Agami R.
Nat Rev Cancer. 2011 Aug 5;11(9):644-56.
miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.
Wang CM, Wang Y, Fan CG, Xu FF, Sun WS, Liu YG, Jia JH.
Biochem Biophys Res Commun. 2011 Aug 5;411(3):586-92.
miRNAs in the spotlight: Understanding cancer gene dependency.
Croce CM.
Nat Med. 2011 Aug 4;17(8):935-6.
Methylation of an intronic region regulates miR-199a in testicular tumor malignancy.
Cheung HH, Davis AJ, Lee TL, Pang AL, Nagrani S, Rennert OM, Chan WY.
Oncogene. 2011 Aug 4;30(31):3404-15.
MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
Gao XN, Lin J, Li YH, Gao L, Wang XR, Wang W, Kang HY, Yan GT, Wang LL, Yu L.
Oncogene. 2011 Aug 4;30(31):3416-28.
miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT.
Xiang X, Zhuang X, Ju S, Zhang S, Jiang H, Mu J, Zhang L, Miller D, Grizzle W, Zhang HG.
Oncogene. 2011 Aug 4;30(31):3440-53.
Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.
Mazar J, DeBlasio D, Govindarajan SS, Zhang S, Perera RJ.
FEBS Lett. 2011 Aug 4;585(15):2467-76.
NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene.
Mattila H, Schindler M, Isotalo J, Ikonen T, Vihinen M, Oja H, Tammela TL, Wahlfors T, Schleutker J.
BMC Cancer. 2011 Aug 2;11:327.
MicroRNAs add an additional layer to the complexity of cell signaling.
Herschkowitz JI, Fu X.
Sci Signal. 2011 Aug 2;4(184):jc5.
Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.
Kubo T, Toyooka S, Tsukuda K, Sakaguchi M, Fukazawa T, Soh J, Asano H, Ueno T, Muraoka T, Yamamoto H, Nasu Y, Kishimoto T, Pass
HI, Matsui H, Huh NH, Miyoshi S.
Clin Cancer Res. 2011 Aug 1;17(15):4965-74.
Inhibition of miR-193a expression by Max and RXRα activates K-Ras and PLAU to mediate distinct aspects of cellular transformation.
Iliopoulos D, Rotem A, Struhl K.
Cancer Res. 2011 Aug 1;71(15):5144-53.
Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche.
Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B, Camussi G.
Cancer Res. 2011 Aug 1;71(15):5346-56.
Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
Xiong F, Wu C, Chang J, Yu D, Xu B, Yuan P, Zhai K, Xu J, Tan W, Lin D.
Cancer Res. 2011 Aug 1;71(15):5175-81.
MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.
Ibrahim AF, Weirauch U, Thomas M, Grünweller A, Hartmann RK, Aigner A.
Cancer Res. 2011 Aug 1;71(15):5214-24.
MicroRNA expression and outcome in resected NSCLC--letter.
Kageyama S, Takagi Y, Sawada T, Kageyama-Yahara N, Shibuya M.
Cancer Res. 2011 Aug 1;71(15):5357
Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.
Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH.
Cancer Lett. 2011 Aug 1;307(1):26-36.
A prognostic multigene classifier for squamous cell carcinomas of the larynx.
Mirisola V, Mora R, Esposito AI, Guastini L, Tabacchiera F, Paleari L, Amaro A, Angelini G, Dellepiane M, Pfeffer U, Salami A.
Cancer Lett. 2011 Aug 1;307(1):37-46.
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response.
Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, Dutour A, Blay JY, Alberti L.
Int J Cancer. 2011 Aug 1;129(3):680-90.
MicroRNAs patents: the road from bench to bedsides for cancer treatment.
Wu W.
Recent Pat DNA Gene Seq. 2011 Aug;5(2):86-91.
Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent
pathways.
Chen L, Zheng J, Zhang Y, Yang L, Wang J, Ni J, Cui D, Yu C, Cai Z.
Mol Ther. 2011 Aug;19(8):1521-8.
Predicting microRNA modulation in human prostate cancer using a simple String IDentifier (SID1.0).
Albertini MC, Olivieri F, Lazzarini R, Pilolli F, Galli F, Spada G, Accorsi A, Rippo MR, Procopio AD.
J Biomed Inform. 2011 Aug;44(4):615-20.
MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications.
Sana J, Hajduch M, Michalek J, Vyzula R, Slaby O.
J Cell Mol Med. 2011 Aug;15(8):1636-44.
Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours.
Fustino N, Rakheja D, Ateek CS, Neumann JC, Amatruda JF.
Int J Androl. 2011 Aug;34(4 Pt 2):e218-33.
Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Sakurai D, Fujimura L, Kawakami K, Chiyomaru T, Yoshino H, Enokida H, Nakagawa M,
Okamoto Y, Seki N.
J Hum Genet. 2011 Aug;56(8):595-601.
A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia.
Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, Shapiro M, Thorley-Lawson DA.
PLoS Pathog. 2011 Aug;7(8):e1002193.
Implication of miRNA in the diagnosis and treatment of breast cancer.
Castañeda CA, Agullo-Ortuño MT, Fresno Vara JA, Cortes-Funes H, Gomez HL, Ciruelos E.
Expert Rev Anticancer Ther. 2011 Aug;11(8):1265-75.
Roles and mechanisms of microRNAs in pancreatic cancer.
Zhang L, Jamaluddin MS, Weakley SM, Yao Q, Chen C.
World J Surg. 2011 Aug;35(8):1725-31.
miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation.
Borze I, Scheinin I, Siitonen S, Elonen E, Juvonen E, Knuutila S.
Leuk Lymphoma. 2011 Aug;52(8):1567-73.
MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, Hornicek F.
Mol Cancer Ther. 2011 Aug;10(8):1337-45.
Reply to "Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b".
Cohen SM.
Toxicol Sci. 2011 Aug;122(2):606
MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression.
Wang Y, Huang JW, Li M, Cavenee WK, Mitchell PS, Zhou X, Tewari M, Furnari FB, Taniguchi T.
Mol Cancer Res. 2011 Aug;9(8):1100-11.
miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
Yang CJ, Shen WG, Liu CJ, Chen YW, Lu HH, Tsai MM, Lin SC.
J Oral Pathol Med. 2011 Aug;40(7):560-6.
MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer.
Ohuchida K, Mizumoto K, Kayashima T, Fujita H, Moriyama T, Ohtsuka T, Ueda J, Nagai E, Hashizume M, Tanaka M.
Ann Surg Oncol. 2011 Aug;18(8):2381-7.
Harnessing the tumor suppressor function of FOXO as an alternative therapeutic approach in cancer.
Singh A, Plati J, Khosravi-Far R.
Curr Drug Targets. 2011 Aug;12(9):1311-21.
Biology of hepatic cancer stem cells.
Tong CM, Ma S, Guan XY.
J Gastroenterol Hepatol. 2011 Aug;26(8):1229-37.
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the
Primary Therapy of Early Breast Cancer 2011.
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ; Panel members.
Ann Oncol. 2011 Aug;22(8):1736-47.
The hepatitis B virus-associated estrogen receptor alpha (ERalpha) was regulated by microRNA-130a in HepG2.2.15 human
hepatocellular carcinoma cells.
Tang L, Pu Y, Wong DK, Liu T, Tang H, Xiang T, Yuen MF, Ren G.
Acta Biochim Biophys Sin (Shanghai). 2011 Aug;43(8):640-6.
Resveratrol and prostate cancer: promising role for microRNAs.
Dhar S, Hicks C, Levenson AS.
Mol Nutr Food Res. 2011 Aug;55(8):1219-29.
MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease.
Wang J, Sen S.
J Biosci. 2011 Aug;36(3):481-91.
Circulating miRNA signature for early diagnosis of lung cancer.
Lin PY, Yang PC.
EMBO Mol Med. 2011 Aug;3(8):436-7.
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer.
Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, Bernard L, Pelosi G, Maisonneuve P, Veronesi G, Di Fiore PP.
EMBO Mol Med. 2011 Aug;3(8):495-503.
Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer.
Nymark P, Guled M, Borze I, Faisal A, Lahti L, Salmenkivi K, Kettunen E, Anttila S, Knuutila S.
Genes Chromosomes Cancer. 2011 Aug;50(8):585-97.
Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13q14 deletion.
Bartuma H, Nord KH, Macchia G, Isaksson M, Nilsson J, Domanski HA, Mandahl N, Mertens F.
Genes Chromosomes Cancer. 2011 Aug;50(8):619-32.
MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells.
Feng S, Cong S, Zhang X, Bao X, Wang W, Li H, Wang Z, Wang G, Xu J, Du B, Qu D, Xiong W, Yin M, Ren X, Wang F, He J, Zhang B.
Nucleic Acids Res. 2011 Aug;39(15):6669-78.
NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after
serum deprivation, providing evidence for a novel negative auto-regulatory loop.
Wang J, Gu Z, Ni P, Qiao Y, Chen C, Liu X, Lin J, Chen N, Fan Q.
Nucleic Acids Res. 2011 Aug;39(15):6440-55.
MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells.
Guo Y, Li S, Qu J, Wang S, Dang Y, Fan J, Yu S, Zhang J.
Mol Cell Biochem. 2011 Aug;354(1-2):275-82.
Targeting miR-375 in gastric cancer.
Xu Y, Deng Y, Yan X, Zhou T.
Expert Opin Ther Targets. 2011 Aug;15(8):961-72.
miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma.
Zhang A, Liu Y, Shen Y, Xu Y, Li X.
Urology. 2011 Aug;78(2):474.e13-9.
MicroRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6.
Saito K, Kondo E, Matsushita M.
Nucleic Acids Res. 2011 Aug;39(14):6086-99.
Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma.
Zhang Y, Song WJ, Zhang FQ, Liu WH, Dou KF.
Dig Dis Sci. 2011 Aug;56(8):2473-81.
The role of microRNA-150 as a tumor suppressor in malignant lymphoma.
Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T, Shimizu N,
Sawada K.
Leukemia. 2011 Aug;25(8):1324-34.
Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful
neoadjuvant chemoradiotherapy.
Drebber U, Lay M, Wedemeyer I, Vallböhmer D, Bollschweiler E, Brabender J, Mönig SP, Hölscher AH, Dienes HP, Odenthal M.
Int J Oncol. 2011 Aug;39(2):409-15.
miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer.
Akçakaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H, Lui WO.
Int J Oncol. 2011 Aug;39(2):311-8.
Molecular classification of hepatocellular carcinoma anno 2011.
van Malenstein H, van Pelt J, Verslype C.
Eur J Cancer. 2011 Aug;47(12):1789-97.
Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with
concurrent Bcl-2 and c-Myc overexpression.
Sasaki N, Kuroda J, Nagoshi H, Yamamoto M, Kobayashi S, Tsutsumi Y, Kobayashi T, Shimura Y, Matsumoto Y, Taki T, Nishida K,
Horiike S, Akao Y, Taniwaki M.
Exp Hematol. 2011 Aug;39(8):817-28.e1.
Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement
attack.
Shan C, Zhang S, Cui W, You X, Kong G, Du Y, Qiu L, Ye L, Zhang X.
Carcinogenesis. 2011 Aug;32(8):1190-7.
Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C.
Carcinogenesis. 2011 Aug;32(8):1183-9.
MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT, Wang JL, Du W, Hong J, Zhao SL, Wang YC, Xiong H, Chen HM, Fang JY.
Carcinogenesis. 2011 Aug;32(8):1207-15.
MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management.
Lu L, Schwartz P, Scarampi L, Rutherford T, Canuto EM, Yu H, Katsaros D.
Gynecol Oncol. 2011 Aug;122(2):366-71.
Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.
Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marmé F, Sültmann H, Altevogt P.
Gynecol Oncol. 2011 Aug;122(2):437-46.
Analyzing miRNAs in ductal adenocarcinomas of the pancreas.
Mees ST, Schleicher C, Mardin WA, Senninger N, Colombo-Benkmann M, Haier J.
J Surg Res. 2011 Aug;169(2):241-6.
Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer.
Torres A, Torres K, Paszkowski T, Jodłowska-Jędrych B, Radomański T, Książek A, Maciejewski R.
Tumour Biol. 2011 Aug;32(4):769-76.
A specific miRNA signature in the peripheral blood of glioblastoma patients.
Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, Weller M, Keller A.
J Neurochem. 2011 Aug;118(3):449-57.
Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29.
Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, Lu W, Wan X, Ma D, Xie X.
J Pathol. 2011 Aug;224(4):484-95.
EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells.
De Weer A, Van der Meulen J, Rondou P, Taghon T, Konrad TA, De Preter K, Mestdagh P, Van Maerken T, Van Roy N, Jeison M, Yaniv I,
Cauwelier B, Noens L, Poirel HA, Vandenberghe P, Lambert F, De Paepe A, Sánchez MG, Odero M, Verhasselt B, Philippé J,
Vandesompele J, Wieser R, Dastugue N, Van Vlierberghe P, Poppe B, Speleman F.
Br J Haematol. 2011 Aug;154(3):337-48.
Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles.
Muralidhar B, Winder D, Murray M, Palmer R, Barbosa-Morais N, Saini H, Roberts I, Pett M, Coleman N.
J Pathol. 2011 Aug;224(4):496-507.
MicroRNAs in colorectal cancer metastasis.
de Krijger I, Mekenkamp LJ, Punt CJ, Nagtegaal ID.
J Pathol. 2011 Aug;224(4):438-47.
MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers.
Nugent M, Miller N, Kerin MJ.
Eur J Surg Oncol. 2011 Aug;37(8):649-54.
Unknown primary tumors.
Natoli C, Ramazzotti V, Nappi O, Giacomini P, Palmeri S, Salvatore M, Landriscina M, Zilli M, Natali PG, Tinari N, Iacobelli S.
Biochim Biophys Acta. 2011 Aug;1816(1):13-24.
A miR-centric view of head and neck cancers.
Babu JM, Prathibha R, Jijith VS, Hariharan R, Pillai MR.
Biochim Biophys Acta. 2011 Aug;1816(1):67-72.
Role of nuclear receptor SHP in metabolism and cancer.
Zhang Y, Hagedorn CH, Wang L.
Biochim Biophys Acta. 2011 Aug;1812(8):893-908.
MicroRNA profiling in cancer.
Munker R, Calin GA.
Clin Sci (Lond). 2011 Aug;121(4):141-58.
Heparin impairs angiogenesis through inhibition of microRNA-10b.
Shen X, Fang J, Lv X, Pei Z, Wang Y, Jiang S, Ding K.
J Biol Chem. 2011 Jul 29;286(30):26616-27.
Pulmonary gene and microRNA expression changes in mice exposed to benzo(a)pyrene by oral gavage.
Halappanavar S, Wu D, Williams A, Kuo B, Godschalk RW, Van Schooten FJ, Yauk CL.
Toxicology. 2011 Jul 29;285(3):133-41.
Hepatitis B virus and hepatocellular carcinoma at the miRNA level.
Zhang ZZ, Liu X, Wang DQ, Teng MK, Niu LW, Huang AL, Liang Z.
World J Gastroenterol. 2011 Jul 28;17(28):3353-8.
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.
Montes-Moreno S, Martinez N, Sanchez-Espiridión B, Díaz Uriarte R, Rodriguez ME, Saez A, Montalbán C, Gomez G, Pisano DG, García
JF, Conde E, Gonzalez-Barca E, Lopez A, Mollejo M, Grande C, Martinez MA, Dunphy C, Hsi ED, Rocque GB, Chang J, Go RS, Visco C,
Xu-Monette Z, Young KH, Piris MA.
Blood. 2011 Jul 28;118(4):1034-40.
Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous
gene COPZ1.
Shtutman M, Baig M, Levina E, Hurteau G, Lim CU, Broude E, Nikiforov M, Harkins TT, Carmack CS, Ding Y, Wieland F, Buttyan R,
Roninson IB.
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12449-54.
FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway.
Kottakis F, Polytarchou C, Foltopoulou P, Sanidas I, Kampranis SC, Tsichlis PN.
Mol Cell. 2011 Jul 22;43(2):285-98.
miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells.
Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q.
J Biol Chem. 2011 Jul 22;286(29):25992-6002.
MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may
contribute to tumorigenesis.
Tian RQ, Wang XH, Hou LJ, Jia WH, Yang Q, Li YX, Liu M, Li X, Tang H.
J Biol Chem. 2011 Jul 22;286(29):25556-63.
miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
Tan S, Li R, Ding K, Lobie PE, Zhu T.
FEBS Lett. 2011 Jul 21;585(14):2229-34.
miRNA and vascular cell movement.
Yue J.
Adv Drug Deliv Rev. 2011 Jul 18;63(8):616-22.
Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7.
Duex JE, Comeau L, Sorkin A, Purow B, Kefas B.
J Biol Chem. 2011 Jul 15;286(28):25377-86.
MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic
implications in NK/T cell lymphoma.
Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, Kim CW.
Clin Cancer Res. 2011 Jul 15;17(14):4761-71.
MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential
therapeutic targets.
Abraham D, Jackson N, Gundara JS, Zhao J, Gill AJ, Delbridge L, Robinson BG, Sidhu SB.
Clin Cancer Res. 2011 Jul 15;17(14):4772-81.
Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth
factor-A predicts poor survival.
Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW, Al-Shibli K, Al-Saad S, Andersen S, Stenvold H, Bremnes RM, Busund LT.
Cancer. 2011 Jul 15;117(14):3193-200.
MicroRNA expression profiling for molecular classification of pediatric brain tumors.
Sredni ST, Huang CC, Bonaldo Mde F, Tomita T.
Pediatr Blood Cancer. 2011 Jul 15;57(1):183-4.
Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome.
Zuo Z, Calin GA, de Paula HM, Medeiros LJ, Fernandez MH, Shimizu M, Garcia-Manero G, Bueso-Ramos CE.
Blood. 2011 Jul 14;118(2):413-5.
Epstein-Barr virus microRNAs and lung cancer.
Koshiol J, Gulley ML, Zhao Y, Rubagotti M, Marincola FM, Rotunno M, Tang W, Bergen AW, Bertazzi PA, Roy D, Pesatori AC, Linnoila I,
Dittmer D, Goldstein AM, Caporaso NE, McShane LM, Wang E, Landi MT.
Br J Cancer. 2011 Jul 12;105(2):320-6.
Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified
neuroblastoma.
Buechner J, Tømte E, Haug BH, Henriksen JR, Løkke C, Flægstad T, Einvik C.
Br J Cancer. 2011 Jul 12;105(2):296-303.
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.
Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, Rakus JF, Dankert JF, Shang S, Kerbel RS,
Bhardwaj N, Shao Y, Darvishian F, Zavadil J, Erlebacher A, Mahal LK, Osman I, Hernando E.
Cancer Cell. 2011 Jul 12;20(1):104-18.
MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells.
Xie QH, He XX, Chang Y, Sun SZ, Jiang X, Li PY, Lin JS.
Biochem Biophys Res Commun. 2011 Jul 8;410(3):440-5.
Dysregulation of microRNAs in cancer: playing with fire.
Melo SA, Esteller M.
FEBS Lett. 2011 Jul 7;585(13):2087-99.
Integration and analysis of genome-scale data from gliomas.
Riddick G, Fine HA.
Nat Rev Neurol. 2011 Jul 5;7(8):439-50.
Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.
Mori Y, Olaru AV, Cheng Y, Agarwal R, Yang J, Luvsanjav D, Yu W, Selaru FM, Hutfless S, Lazarev M, Kwon JH, Brant SR, Marohn MR,
Hutcheon DF, Duncan MD, Goel A, Meltzer SJ.
Endocr Relat Cancer. 2011 Jul 4;18(4):465-78.
Clinical significance of miR-146a in gastric cancer cases.
Kogo R, Mimori K, Tanaka F, Komune S, Mori M.
Clin Cancer Res. 2011 Jul 1;17(13):4277-84.
MicroRNA sequence and expression analysis in breast tumors by deep sequencing.
Farazi TA, Horlings HM, Ten Hoeve JJ, Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F, van Kouwenhove M, Kreike B,
Sie D, Hovestadt V, Wessels LF, van de Vijver MJ, Tuschl T.
Cancer Res. 2011 Jul 1;71(13):4443-53.
Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation.
Polytarchou C, Iliopoulos D, Hatziapostolou M, Kottakis F, Maroulakou I, Struhl K, Tsichlis PN.
Cancer Res. 2011 Jul 1;71(13):4720-31.
Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21.
Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama
Y, Aburatani H, Harris CC, Nakagama H.
Cancer Res. 2011 Jul 1;71(13):4628-39.
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-
34a/SIRT1 tumor suppressor network.
Audrito V, Vaisitti T, Rossi D, Gottardi D, D'Arena G, Laurenti L, Gaidano G, Malavasi F, Deaglio S.
Cancer Res. 2011 Jul 1;71(13):4473-83.
HIF induces human embryonic stem cell markers in cancer cells.
Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CM, Hubaud A, Stadler B, Choi M, Bar M, Tewari M, Liu A, Vessella R,
Rostomily R, Born D, Horwitz M, Ware C, Blau CA, Cleary MA, Rich JN, Ruohola-Baker H.
Cancer Res. 2011 Jul 1;71(13):4640-52.
Are microRNAs involved in the endocrine-specific pattern of tumorigenesis in multiple endocrine neoplasia type 1?
Luzi E, Brandi ML.
Endocr Pract. 2011 Jul-Aug;17 Suppl 3:58-63.
Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival.
Delfino KR, Serão NV, Southey BR, Rodriguez-Zas SL.
Cancer Genomics Proteomics. 2011 Jul-Aug;8(4):173-83.
[MiRNAs in follicular thyroid tumors].
Le Pennec S, Savagner F.
Presse Med. 2011 Jul-Aug;40(7-8):683-9.
[Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
Zhang JM, Sun CY, Yu SZ, Wang Q, An TL, Li YY, Kong YL, Wen YJ.
Zhonghua Bing Li Xue Za Zhi. 2011 Jul;40(7):454-9.
[Effects of microRNA-155 on the growth of human lung cancer cell line 95D
in vitro].
Qin A, Zhou Y, Sheng M, Fei G, Ren T, Xu L.
Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):575-80.
[Molecular diagnostics for monitoring and predicting therapeutic effect in cancer].
Cho WC.
Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):C1-5.
Regulation of vascular endothelial growth factor signaling by miR-200b.
Choi YC, Yoon S, Jeong Y, Yoon J, Baek K.
Mol Cells. 2011 Jul;32(1):77-82.
Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma.
Yang F, Zhang L, Wang F, Wang Y, Huo XS, Yin YX, Wang YQ, Zhang L, Sun SH.
Neoplasia. 2011 Jul;13(7):590-600.
miRNA profiling along tumour progression in ovarian carcinoma.
Vaksman O, Stavnes HT, Kaern J, Trope CG, Davidson B, Reich R.
J Cell Mol Med. 2011 Jul;15(7):1593-602.
Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo.
Hao Y, Gu X, Zhao Y, Greene S, Sha W, Smoot DT, Califano J, Wu TC, Pang X.
Cancer Prev Res (Phila). 2011 Jul;4(7):1073-83.
miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, Sun L, Ji G, Shi Y, Han Z, Han S, Nie Y, Chen X, Zhao Q, Ding J, Wu K, Daiming F.
Mol Cancer Res. 2011 Jul;9(7):824-33.
EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1
regulators.
Zhu H, Dougherty U, Robinson V, Mustafi R, Pekow J, Kupfer S, Li YC, Hart J, Goss K, Fichera A, Joseph L, Bissonnette M.
Mol Cancer Res. 2011 Jul;9(7):960-75.
MicroRNA signatures: novel biomarker for colorectal cancer?
Luo X, Burwinkel B, Tao S, Brenner H.
Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1272-86.
Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.
Wang L, Alcon A, Yuan H, Ho J, Li QJ, Martins-Green M.
Integr Biol (Camb). 2011 Jul;3(7):742-54.
Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy.
Long Q, Johnson BA, Osunkoya AO, Lai YH, Zhou W, Abramovitz M, Xia M, Bouzyk MB, Nam RK, Sugar L, Stanimirovic A, Williams DJ,
Leyland-Jones BR, Seth AK, Petros JA, Moreno CS.
Am J Pathol. 2011 Jul;179(1):46-54.
Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells.
Tsunoda T, Takashima Y, Yoshida Y, Doi K, Tanaka Y, Fujimoto T, Machida T, Ota T, Koyanagi M, Kuroki M, Sasazuki T, Shirasawa S.
Anticancer Res. 2011 Jul;31(7):2453-9.
Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact.
Leivonen SK, Rokka A, Ostling P, Kohonen P, Corthals GL, Kallioniemi O, Perälä M.
Mol Cell Proteomics. 2011 Jul;10(7):M110.005322.
Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
Singh P, Srinivasan R, Wig JD.
Pancreas. 2011 Jul;40(5):644-52.
Shielding the messenger (RNA): microRNA-based anticancer therapies.
Sotillo E, Thomas-Tikhonenko A.
Pharmacol Ther. 2011 Jul;131(1):18-32.
MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
Yip L, Kelly L, Shuai Y, Armstrong MJ, Nikiforov YE, Carty SE, Nikiforova MN.
Ann Surg Oncol. 2011 Jul;18(7):2035-41.
Molecular mechanism of liver cancer.
Pan H, Fu X, Huang W.
Anticancer Agents Med Chem. 2011 Jul;11(6):493-9.
microRNA involvement in hepatocellular carcinoma.
Negrini M, Gramantieri L, Sabbioni S, Croce CM.
Anticancer Agents Med Chem. 2011 Jul;11(6):500-21.
Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells.
Wang F, Ding W, Wang J, Jing R, Wang X, Cong H, Wang Y, Ju S, Wang H.
Cancer Gene Ther. 2011 Jul;18(7):500-9.
The 12th international conference on differentiation therapy: targeting the aberrant growth, differentiation and cell death programs of cancer
cells.
Pettersson F, Miller WH Jr, Nervi C, Gronemeyer HJ, Licht J, Tallman MS, Waxman S.
Cell Death Differ. 2011 Jul;18(7):1231-3.
MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2.
Foley NH, Bray I, Watters KM, Das S, Bryan K, Bernas T, Prehn JH, Stallings RL.
Cell Death Differ. 2011 Jul;18(7):1089-98.
Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells.
Huang Y, Chuang A, Hao H, Talbot C, Sen T, Trink B, Sidransky D, Ratovitski E.
Cell Death Differ. 2011 Jul;18(7):1220-30.
Whole mouse blood microRNA as biomarkers for exposure to γ-rays and (56)Fe ion.
Templin T, Amundson SA, Brenner DJ, Smilenov LB.
Int J Radiat Biol. 2011 Jul;87(7):653-62.
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
Martelli AM, Evangelisti C, Chappell W, Abrams SL, Bäsecke J, Stivala F, Donia M, Fagone P, Nicoletti F, Libra M, Ruvolo V, Ruvolo P,
Kempf CR, Steelman LS, McCubrey JA.
Leukemia. 2011 Jul;25(7):1064-79.
miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression.
Ding DP, Chen ZL, Zhao XH, Wang JW, Sun J, Wang Z, Tan FW, Tan XG, Li BZ, Zhou F, Shao K, Li N, Qiu B, He J.
Carcinogenesis. 2011 Jul;32(7):1025-32.
MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.
Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Pan Z, Kang T, Huang W.
Carcinogenesis. 2011 Jul;32(7):1033-42.
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
Haug BH, Henriksen JR, Buechner J, Geerts D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B, Einvik C.
Carcinogenesis. 2011 Jul;32(7):1005-12.
The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers.
Porkka KP, Ogg EL, Saramäki OR, Vessella RL, Pukkila H, Lähdesmäki H, van Weerden WM, Wolf M, Kallioniemi OP, Jenster G,
Visakorpi T.
Genes Chromosomes Cancer. 2011 Jul;50(7):499-509.
miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
Int J Oncol. 2011 Jul;39(1):13-21.
A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.
Yang H, Li TW, Peng J, Tang X, Ko KS, Xia M, Aller MA.
Gastroenterology. 2011 Jul;141(1):378-88, 388.e1-4.
Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis.
Nakamura I, Roberts LR.
Gastroenterology. 2011 Jul;141(1):32-4.
MicroRNAs as regulators of signal transduction in urological tumors.
Fendler A, Stephan C, Yousef GM, Jung K.
Clin Chem. 2011 Jul;57(7):954-68.
A novel microRNA mmu-miR-466h affects apoptosis regulation in mammalian cells.
Druz A, Chu C, Majors B, Santuary R, Betenbaugh M, Shiloach J.
Biotechnol Bioeng. 2011 Jul;108(7):1651-61.
MicroRNAs and their predicted target messenger RNAs are deregulated by exposure to a carcinogenic dose of comfrey in rat liver.
Li Z, Fuscoe JC, Chen T.
Environ Mol Mutagen. 2011 Jul;52(6):469-78.
MicroRNA-21 and PDCD4 expression in colorectal cancer.
Chang KH, Miller N, Kheirelseid EA, Ingoldsby H, Hennessy E, Curran CE, Curran S, Smith MJ, Regan M, McAnena OJ, Kerin MJ.
Eur J Surg Oncol. 2011 Jul;37(7):597-603.
A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-
phosphate dehydrogenase 1-like.
Kelly TJ, Souza AL, Clish CB, Puigserver P.
Mol Cell Biol. 2011 Jul;31(13):2696-706.
Recent progress in carcinogenesis, progression and therapy of breast cancer: the 20th Hiroshima Cancer Seminar--the 4th Three
Universities' Consortium International Symposium, October 2010: 31 October 2010, International Conference Center Hiroshima.
Toi M, Yasui W, Ito H, Tahara E.
Jpn J Clin Oncol. 2011 Jul;41(7):924-30.
miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.
Chen Q, Chen X, Zhang M, Fan Q, Luo S, Cao X.
Dig Dis Sci. 2011 Jul;56(7):2009-16.
MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?
Lopotová T, Záčková M, Klamová H, Moravcová J.
Leuk Res. 2011 Jul;35(7):974-7.
Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma.
Zhou B, Wang K, Wang Y, Xi M, Zhang Z, Song Y, Zhang L.
Mol Carcinog. 2011 Jul;50(7):499-505.
Post-transcriptional up-regulation of miR-21 by type I collagen.
Li C, Nguyen HT, Zhuang Y, Lin Y, Flemington EK, Guo W, Guenther J, Burow ME, Morris GF, Sullivan D, Shan B.
Mol Carcinog. 2011 Jul;50(7):563-70.
MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
Wu Q, Guo R, Lin M, Zhou B, Wang Y.
Gynecol Oncol. 2011 Jul;122(1):149-54.
5-Fluorouracil drug alters the microRNA expression profiles in MCF-7 breast cancer cells.
Shah MY, Pan X, Fix LN, Farwell MA, Zhang B.
J Cell Physiol. 2011 Jul;226(7):1868-78.